Showing results (151-160 of 618) with videos related to
Sort By:
Pageof 62
Current Oncology Reports|February 9, 2006
Targeted molecular therapy of malignant gliomasSantosh Kesari, Naren Ramakrishna, Claire Sauvageot, et al.Journal of Neuro-Oncology|September 27, 2007
Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphomaAlfredo D Voloschin, Rebecca Betensky, Patrick Y Wen, et al.JAMA Oncology|August 25, 2022
World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A ReviewTamar R Berger, Patrick Y Wen, Melanie Lang-Orsini, et al.Frontiers in Neurology|March 11, 2015
Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining responseRaymond Y Huang, Martha R Neagu, David A Reardon, et al.Investigational New Drugs|November 13, 2014
Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastomaDavid Schiff, Santosh Kesari, John de Groot, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2010
Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastomaTracy T Batchelor, Dan G Duda, Emmanuelle di Tomaso, et al.Neuro-Oncology|October 27, 2012
Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02Eudocia Q Lee, John Kuhn, Kathleen R Lamborn, et al.JCO Precision Oncology|September 11, 2020
Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With GlioblastomaBrian M Alexander, Lorenzo Trippa, Sarah Gaffey, et al.International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastomaPhioanh Leia Nghiemphu, Patrick Y Wen, Kathleen R Lamborn, et al.Neuro-Oncology|January 10, 2015
Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic gliomaEudocia Q Lee, David A Reardon, David Schiff, et al.Pageof 62